Epitope-Based Multimeric Subunit Vaccine (ATOMSSUISpenta) Confers Broad Protection Against Streptococcus suis Infection
The Journal of Infectious Diseases · 15.05.2026 · 233 (5) · 899-911
DOI: 10.1093/infdis/jiag131 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 04.03.2026. Verfasst von Sun-Young Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cyclotron Applied Research Section, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea. Hauptthemen laut MEDLINE: Streptococcus suis, Streptococcal Infections, Streptococcal Vaccines, Epitopes, B-Lymphocyte. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Korea Atomic Energy Research Institute, Ministry of Science and ICT, Ministry of Food and Drug Safety.
Abstract (Originalsprache)
Background
Streptococcus suis (S. suis) is a zoonotic pathogen causing economic losses in the swine industry and severe human infections. High serotype variability and genomic diversity of S. suis hinder cross-protective vaccine development. Although advances in in silico prediction-driven antigen discovery have accelerated protein vaccine development, discrepancies between predicted immunogenicity and experimentally verified protection in animal models emphasize the need to integrate computational design with empirical validation.
Methods
Using an in silico design strategy, predicted T- and B-cell epitope-rich domains from S. suis antigens (HP0197, Fnbp, Sao, ScpB, and SLY) were assembled into a multimeric vaccine, ATOMSSUISpenta, optimized for predicted immunogenicity, solubility, and allergenicity. Vaccine efficacy was evaluated in mice through antibody profiling, cellular immunity analysis, and assessment of cross-serotype immunity.
Results
ATOMSSUISpenta elicited strong humoral responses against all component antigens. The vaccine also induced Th1- and Th17-type cellular responses, critical for opsonic and mucosal defense against S. suis. In addition, ATOMSSUISpenta conferred significant protection in a S. suis serotype 2 infection and induced opsonic antibodies against serotypes 4 and 9.
Conclusions
These findings highlight ATOMSSUISpenta as a subunit vaccine strategy with potential for broader protection and demonstrate the effectiveness of epitope-based multimeric design against antigenically diverse Gram-positive pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cyclotron Applied Research Section, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.
- School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
- Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup, Republic of Korea.
- Animal Production and Health Laboratory, Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Seibersdorf, Austria.
- Department of Pediatrics, Ewha Womans University Mokdong Hospital, Seoul, Korea.
- Department of Radiation Science, University of Science and Technology, Daejeon, Republic of Korea.
ORCID-Profile: Sun-Young Kim, Min-Kyu Kim, Kyung-Hyo Kim, Ki Bum Ahn, Ho Seong Seo
Förderung
- Korea Atomic Energy Research Institute
- Ministry of Science and ICT
- Ministry of Food and Drug Safety
- National Research Foundation of Korea
- Korean government
- International Atomic Energy Agency
Zitieren
APA
Kim, S. Y., Chen, F., Kim, W. S., Ji, H. J., Kim, M. K., Park, H. R., Lamien, C. E., Wijewardana, V., Kim, K. H., Ahn, K. B., & Seo, H. S. (2026). Epitope-Based Multimeric Subunit Vaccine (ATOMSSUISpenta) Confers Broad Protection Against Streptococcus suis Infection. The Journal of Infectious Diseases, 233(5), 899-911. https://doi.org/10.1093/infdis/jiag131
Vancouver
Kim SY, Chen F, Kim WS, Ji HJ, Kim MK, Park HR, et al. Epitope-Based Multimeric Subunit Vaccine (ATOMSSUISpenta) Confers Broad Protection Against Streptococcus suis Infection. The Journal of Infectious Diseases. 2026;233(5):899-911. doi:10.1093/infdis/jiag131
BibTeX
@article{Kim2026,
author = {Kim, Sun-Young and Chen, Fengjia and Kim, Woo-Sik and Ji, Hyun Jung and Kim, Min-Kyu and Park, Hae Ran and Lamien, Charles Euloge and Wijewardana, Viskam and Kim, Kyung-Hyo and Ahn, Ki Bum and Seo, Ho Seong},
title = {Epitope-Based Multimeric Subunit Vaccine (ATOMSSUISpenta) Confers Broad Protection Against Streptococcus suis Infection},
journal = {The Journal of Infectious Diseases},
year = {2026},
volume = {233},
number = {5},
pages = {899--911},
doi = {10.1093/infdis/jiag131}
}
EUVIMED